Metformin HCl Extended Release Tablets USP 500 mg, Generic for : Glucophage XR, Pkg Size 100, Mfg...

FDA Recall #D-0077-2021 — Class II — November 1, 2020

Recall #D-0077-2021 Date: November 1, 2020 Classification: Class II Status: Terminated

Product Description

Metformin HCl Extended Release Tablets USP 500 mg, Generic for : Glucophage XR, Pkg Size 100, Mfg: Time-Cap Labs, Inc.; Farmingdale, NY, NDC #: 68788-6932-1, Preferred Pharmaceuticals, Inc.

Reason for Recall

CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.

Recalling Firm

Preferred Pharmaceuticals, Inc. — Anaheim, CA

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

99 bottles (9990 Extended Release Tablets)

Distribution

Distributed to two physician's offices located in FL.

Code Information

E0620F, Exp.12/31/2021; G2020M Exp., 04/30/2022

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated